|
|
||||||||
|
FIGURE 2. Correlations between SUVmax and Ki-PAT or Ki-NLR at baseline (A), 1 mo (B), and 6 mo (C) after start of treatment. All correlations were statistically significant (P < 0.05).
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |